ANTICONCEPCIONAIS HORMONAIS COMBINADOS E RISCO TROMBOEMBÓLICO: IMPLICAÇÕES CLÍNICAS E DECISÕES NA PRÁTICA
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Combined hormonal contraceptives constitute one of the most widely used contraceptive methods in gynecological practice, being indicated both for pregnancy prevention and for the management of various gynecological conditions. Despite their effectiveness and associated therapeutic benefits, the use of these agents is linked to an increased risk of thromboembolic events—particularly venous—requiring careful clinical attention. This chapter aims to analyze, through a narrative literature review, the relationship between the use of combined hormonal contraceptives and thromboembolic risk, highlighting the main underlying pathophysiological mechanisms and their implications for gynecological practice. The search was conducted in the PubMed, SciELO, ScienceDirect, and LILACS databases, including studies published between 2010 and 2025. The results indicate that thromboembolic risk is primarily associated with the estrogen component of these formulations and is influenced by hormone dosage, the type of progestogen, and individual factors such as age, smoking, obesity, and a history of thrombosis. It is concluded that the prescription of combined contraceptives should be individualized, based on risk stratification and shared decision-making, in order to ensure greater safety and comprehensive women’s health care.
Fields of Study & Subjects
Venous Thromboembolism Diagnosis and Management
Reproductive Health and Contraception
Blood Coagulation and Thrombosis Mechanisms
Publication details
- Pages
- 1–9
- Publication date
- 24 March 2026
- Language
- EN
- Document type
- Book chapter